Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? - PubMed (original) (raw)
Review
. 1999 May 1;93(9):2755-9.
Affiliations
- PMID: 10216068
Free article
Review
Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?
S Faderl et al. Blood. 1999.
Free article
No abstract available
Comment in
- Clinical decision making in chronic myeloid leukemia based on polymerase chain reaction analysis of minimal residual disease.
Goldman JM, Kaeda JS, Cross NC, Hochhaus A, Hehlmann R. Goldman JM, et al. Blood. 1999 Aug 15;94(4):1484-6. Blood. 1999. PMID: 10484638 No abstract available. - Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.
Moravcová J, Nádvorníková S, Lukásová M, Klamová H. Moravcová J, et al. Blood. 1999 Nov 15;94(10):3609-11. Blood. 1999. PMID: 10610116 No abstract available.
Similar articles
- Detection and quantification of leukemia-specific rearrangements.
Hochhaus A. Hochhaus A. Methods Mol Med. 2002;68:67-96. doi: 10.1385/1-59259-135-3:067. Methods Mol Med. 2002. PMID: 11901513 No abstract available. - Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.
Moravcová J, Nádvorníková S, Lukásová M, Klamová H. Moravcová J, et al. Blood. 1999 Nov 15;94(10):3609-11. Blood. 1999. PMID: 10610116 No abstract available. - A nested RT-PCR assay to detect BCR/abl.
Wasserman LM. Wasserman LM. Methods Mol Med. 2004;97:181-9. doi: 10.1385/1-59259-760-2:181. Methods Mol Med. 2004. PMID: 15064493 No abstract available. - Measuring minimal residual disease in chronic myeloid leukemia: fluorescence in situ hybridization and polymerase chain reaction.
Hughes TP, Branford S. Hughes TP, et al. Clin Lymphoma Myeloma. 2009;9 Suppl 3:S266-71. doi: 10.3816/CLM.2009.s.022. Clin Lymphoma Myeloma. 2009. PMID: 19778851 Review. - The detection and significance of minimal residual disease in chronic myeloid leukemia.
Radich JP. Radich JP. Medicina (B Aires). 2000;60 Suppl 2:66-70. Medicina (B Aires). 2000. PMID: 11188935 Review.
Cited by
- AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
Miyamoto T, Weissman IL, Akashi K. Miyamoto T, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7521-6. doi: 10.1073/pnas.97.13.7521. Proc Natl Acad Sci U S A. 2000. PMID: 10861016 Free PMC article. - Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.
Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK; International neuroblastoma Risk Group Task Force. Beiske K, et al. Br J Cancer. 2009 May 19;100(10):1627-37. doi: 10.1038/sj.bjc.6605029. Epub 2009 Apr 28. Br J Cancer. 2009. PMID: 19401690 Free PMC article. - Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Rosenberg MW, Savage SL, Eide CA, Reister Schultz A, Cook RJ, Press RD, Rempfer C, Eickelberg G, Wilmot B, McWeeney SK, Tyner JW, Druker BJ, Tognon CE. Rosenberg MW, et al. Cold Spring Harb Mol Case Stud. 2022 Oct 28;8(6):a006218. doi: 10.1101/mcs.a006218. Print 2022 Oct. Cold Spring Harb Mol Case Stud. 2022. PMID: 36307214 Free PMC article. - Correlation between BCR-ABL expression and tumor burden is restricted to the transition from minor to major cytogenetic response in interferon treated CML patients.
Kereskai L, Vass JA, Kneif M, Pajor L. Kereskai L, et al. Pathol Oncol Res. 2003;9(3):174-9. doi: 10.1007/BF03033733. Epub 2003 Oct 7. Pathol Oncol Res. 2003. PMID: 14530811 - Coexistence of p210BCR-ABL and CBFβ-MYH11 fusion genes in myeloid leukemia: A report of 4 cases.
Wang YY, Ding WJ, Jiang F, Chen ZX, Cen JN, Qi XF, Liang JY, Liu DD, Pan JL, Chen SN. Wang YY, et al. Oncol Lett. 2017 Nov;14(5):5171-5178. doi: 10.3892/ol.2017.6812. Epub 2017 Aug 24. Oncol Lett. 2017. PMID: 29151902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical